The main focus of our research is investigating therapeutic options for neurodegenerative disorders including Parkinson’s disease and atypical parkinsonian conditions, Alzheimer’s disease and other dementias, Huntington’s disease and Friedreich’s Ataxia.    

Our clinical links through the Royal Brisbane & Women’s Hospital (RBWH) and Surgical Treatment and Rehabilitation Service (STARS) within Metro North Health and St Andrew’s War Memorial and Wesley Hospitals through Uniting Care Health provides the critical connection with patients to facilitate clinical research at UQCCR. 

Our research includes clinical trials involving both novel agents and existing drugs approved for other indications “repurposed” to treat neurodegenerative diseases and thereby accelerating the time it takes to make treatments available for clinical use. This has been facilitated through the co-located Queensland Drug Repurposing Initiative. We are also involved in investigation of biomarkers including utilising neuroimages and biosamples collected from patients to complement clinical assessment in the diagnosis and assessment of disease progression. The co-located Herston Imaging Research Facility (HIRF) and UQCCR Clinical Trial Support Unit and Neuroscience Clinical Research Suite provide critical infrastructure to conduct our research.  

We have received funding from: 

  • Wesley Medical Research 

  • Medical Research Future Fund 

  • Queensland Government - Advance Queensland Innovation Partnerships (AQIP)   

We collaborate closely with other groups within UQCCR